EVALUATION OF CYCLIC-AMP ACCUMULATION IN EBV-TRANSFORMED HUMAN B-LYMPHOCYTES - EFFECTS OF DOPAMINE AGONISTS, ISOPROTERENOL, PROSTAGLANDIN E(1), CHOLERA-TOXIN, FORSKOLIN, AND PHORBOL 12-MYRISTATE-13-ACETATE
N. Natsukari et al., EVALUATION OF CYCLIC-AMP ACCUMULATION IN EBV-TRANSFORMED HUMAN B-LYMPHOCYTES - EFFECTS OF DOPAMINE AGONISTS, ISOPROTERENOL, PROSTAGLANDIN E(1), CHOLERA-TOXIN, FORSKOLIN, AND PHORBOL 12-MYRISTATE-13-ACETATE, Progress in neuro-psychopharmacology & biological psychiatry, 20(1), 1996, pp. 99-108
1. Phorbol 12-myristate-13-acetate (PMA), a protein kinase C activator
, elevated cyclic AMP accumulation in EBV-transformed human B-lymphocy
tes, and potentiated isoproterenol-, prostaglandin- (PGE(1)), cholera
toxin-, and forskolin-stimulated cyclic AMP accumulation. 2. The dopam
ine D-1 receptor agonist, SXF38393 (10(-7) to 10(-5) M), had no effect
on cyclic AMP accumulation in transformed human B-lymphocytes. 3. The
dopamine D-2 receptor agonist, quinpirole (10(-7) to 10(-4) M) did no
t inhibit cyclic AMP accumulation even when cyclic AMP accumulation wa
s maximized by the addition of PMA and forskolin. 4. These data sugges
t that dopamine D-1- and D-2-receptor coupling to a cyclic AMP generat
ing system is not present at detectable levels in transformed human B-
lymphocytes.